SLC43A1 and cancer: To investigate whether LAT3 may play a role in sensitivity to other platinum-based anti-cancer agents, we treated SW620 and RKO LAT3KO and LAT3OE cells with cisplatin, carboplatin, or phenanthriplatin, and measured cell viability after 72 hours.